Your browser doesn't support javascript.
loading
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models.
Del Curatolo, Anais; Conciatori, Fabiana; Cesta Incani, Ursula; Bazzichetto, Chiara; Falcone, Italia; Corbo, Vincenzo; D'Agosto, Sabrina; Eramo, Adriana; Sette, Giovanni; Sperduti, Isabella; De Luca, Teresa; Marabese, Mirko; Shirasawa, Senji; De Maria, Ruggero; Scarpa, Aldo; Broggini, Massimo; Del Bufalo, Donatella; Cognetti, Francesco; Milella, Michele; Ciuffreda, Ludovica.
Afiliação
  • Del Curatolo A; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Conciatori F; ARC-Net Research Centre and Department of Pathology, University of Verona, Verona, Italy.
  • Cesta Incani U; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Bazzichetto C; University of Rome "La Sapienza", Rome, Italy.
  • Falcone I; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Corbo V; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • D'Agosto S; University of Rome "La Sapienza", Rome, Italy.
  • Eramo A; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Sette G; ARC-Net Research Centre and Department of Pathology, University of Verona, Verona, Italy.
  • Sperduti I; ARC-Net Research Centre and Department of Pathology, University of Verona, Verona, Italy.
  • De Luca T; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Marabese M; Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Shirasawa S; Biostatistics, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • De Maria R; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Scarpa A; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Broggini M; Central Research Institute for Advanced Molecular Medicine, Fukuoka University, Fukuoka, Japan.
  • Del Bufalo D; Institute of General Pathology, Catholic University of the Sacred Heart, Rome, Italy.
  • Cognetti F; ARC-Net Research Centre and Department of Pathology, University of Verona, Verona, Italy.
  • Milella M; Laboratory of Molecular Pharmacology, Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.
  • Ciuffreda L; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
J Exp Clin Cancer Res ; 37(1): 140, 2018 Jul 09.
Article em En | MEDLINE | ID: mdl-29986755
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases de Proteína Quinase Ativadas por Mitógeno / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália